Detecting chromosomal alterations at 1p and 19q by FISH and DNA fragment analysis--a comparative study in human gliomas
- PMID: 19130734
- DOI: 10.5414/npp27378
Detecting chromosomal alterations at 1p and 19q by FISH and DNA fragment analysis--a comparative study in human gliomas
Abstract
Histological classification of gliomas is important for treatment and as a prognostic predictor, but classification by histology alone can be a challenge. Molecular genetic investigations, in particular the combined loss of the short arm of chromosome 1 and the long arm of chromosome 19 (LOH1p/19q), has become a significant predictor of outcome in oligodendrogliomas. 1p/19q alterations can be investigated by fluorescence in situ hybridization (FISH), but controversies persist in the interpretation ofresults. Another technique is polymerase chain reaction (PCR) analysis using microsatellites as primers and capillary electrophoresis or southern blot as detection method. The objective of the present study was to compare the accuracy, reliability and feasibility of detecting chromosomal changes at 1p/19q with PCR microsatellite analysis and FISH in glial tumors in the clinical laboratory, where often only small formalin-fixed paraffin-embedded samples are available. Commercial DNA and normal cortex were used for comparison. The material comprised 41 glial tumors including 10 oligodendrogliomas (WHO Grades II and III, 5 each), 10 mixed oligoastrocytomas (WHO Grades II and III, 5 each), 10 astrocytomas (WHO Grades II and III, 5 each), and 11 glioblastomas (WHO Grade IV). Our data confirmed a correlation between FISH and LOH fragment analysis in classical oligodendrogliomas and in mixed oligoastrocytomas. Disparity was found among the glioblastomas, where fragment analysis showed 1p/19q loss in three cases, with no changes detected by FISH. The fragment analysis seems reliable and implementable for LOH 1p/19q investigation without patient-related control material.
Similar articles
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
[Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].Ugeskr Laeger. 2006 Oct 30;168(44):3813-6. Ugeskr Laeger. 2006. PMID: 17118240 Danish.
-
[Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):752-8. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22335907 Chinese.
-
[Histological and molecular classification of gliomas].Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):505-15. doi: 10.1016/j.neurol.2008.03.011. Epub 2008 Jun 10. Rev Neurol (Paris). 2008. PMID: 18565348 Review. French.
-
[Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):595-604. doi: 10.1016/j.neurol.2008.04.002. Epub 2008 May 21. Rev Neurol (Paris). 2008. PMID: 18565359 Review. French.
Cited by
-
Something old and something new about molecular diagnostics in gliomas.Surg Pathol Clin. 2012 Dec 1;5(4):919-939. doi: 10.1016/j.path.2012.09.001. Surg Pathol Clin. 2012. PMID: 23459421 Free PMC article.
-
Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.PLoS One. 2017 Nov 29;12(11):e0188419. doi: 10.1371/journal.pone.0188419. eCollection 2017. PLoS One. 2017. PMID: 29186201 Free PMC article. Review.
-
The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.J Neuropathol Exp Neurol. 2012 Jan;71(1):73-82. doi: 10.1097/NEN.0b013e318240fa65. J Neuropathol Exp Neurol. 2012. PMID: 22157622 Free PMC article.
-
PROX1 is a predictor of survival for gliomas WHO grade II.Br J Cancer. 2011 May 24;104(11):1747-54. doi: 10.1038/bjc.2011.162. Epub 2011 May 10. Br J Cancer. 2011. PMID: 21559010 Free PMC article.
-
Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors.Molecules. 2020 Apr 17;25(8):1864. doi: 10.3390/molecules25081864. Molecules. 2020. PMID: 32316657 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources